Cargando…
Retraction: Resveratrol inhibits matrix metalloproteinases to attenuate neuronal damage in cerebral ischemia: a molecular docking study exploring possible neuroprotection
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727430/ https://www.ncbi.nlm.nih.gov/pubmed/36018195 http://dx.doi.org/10.4103/1673-5374.310702 |
Ejemplares similares
-
Resveratrol inhibits matrix metalloproteinases to attenuate neuronal damage in cerebral ischemia: a molecular docking study exploring possible neuroprotection
por: Pandey, Anand Kumar, et al.
Publicado: (2015) -
Corrigendum: Resveratrol inhibits matrix metalloproteinases to attenuate neuronal damage in cerebral ischemia: a molecular docking study exploring possible neuroprotection
Publicado: (2020) -
Expression of Concern: Resveratrol inhibits matrix metalloproteinases to attenuate neuronal damage in cerebral ischemia: a molecular docking study exploring possible neuroprotection
Publicado: (2021) -
Retraction: Nafamostat mesylate attenuates the pathophysiologic sequelae of neurovascular ischemia
Publicado: (2021) -
Retraction: Ki20227 aggravates apoptosis, inflammatory response, and oxidative stress after focal cerebral ischemia injury
Publicado: (2022)